"In our experimental validations we show few examples of how our data can be used to investigate potential mechanisms for disease variants. In the long run, having fully annotated function for each genetic variant in our genomes is essential for the implementation of precision medicine in the clinics," Dr. Luca said.

The study was funded by grants from the National Institute of General Medical Sciences (1R01 GM109215) and the American Heart Association.